Bio-Rad Laboratories logo
Bio-Rad Laboratories BIO
$ 332.72 2.19%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Bio-Rad Laboratories Financial Ratios 2011-2024 | BIO

Annual Financial Ratios Bio-Rad Laboratories

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

28.2 17.3 4.2 4.5 6.2 20.0 62.9 195.3 32.9 37.2 47.3 19.9 16.2

P/S

3.7 5.1 6.1 6.7 4.7 3.2 3.6 2.7 1.8 1.5 1.7 1.6 1.4

EPS

12.2 27.9 142.6 128.1 58.9 12.2 4.1 0.9 3.7 3.1 2.7 5.8 6.4

EV (Enterprise Value)

13 B 17.8 B 21.5 B 19.5 B 12.5 B 8.47 B 8.65 B 6.3 B 4.49 B 4.05 B 4.55 B 4.22 B 3.67 B

EBITDA per Share

16.6 20.8 21.4 18.8 12.2 11 9.34 8.78 10.2 10.4 11.1 13.7 14.8

EV/EBITDA

34.5 40.0 29.5 22.4 27.9 21.2 12.4 11.1 11.9 9.1 7.3

PEG

2.52 0.92 0.2 0.3 0.02 0.09 0.21 -2.6 1.28 2.81 -0.87 -3.33 -3.2

P/B

1.1 1.5 1.3 1.7 1.9 1.8 2.6 2.1 1.5 1.5 1.7 1.6 1.7

P/CF

26.3 73.7 26.7 29.2 30.5 47.0 -683.7 73.4 51.1 24.2 59.5 26.1 18.5

ROE %

4.00 8.61 31.09 38.57 30.56 9.09 4.17 1.09 4.54 4.07 3.56 8.14 10.22

ROA %

2.84 6.13 23.90 29.40 21.96 6.52 2.86 0.73 3.05 2.66 2.30 4.77 5.76

ROCE %

3.86 5.02 3.66 4.26 3.23 3.67 3.40 3.42 5.10 5.18 5.84 8.67 11.19

Current Ratio

3.5 3.5 4.3 4.2 2.4 4.5 3.9 3.9 4.0 3.8 3.6 4.1 3.9

DSO

67.2 59.8 52.6 58.2 62.0 62.6 78.5 65.7 70.8 63.4 72.3 70.3 70.2

DIO

220.0 190.9 169.7 193.8 191.7 199.8 223.2 206.0 199.3 172.5 191.8 178.8 176.7

DPO

41.0 40.9 40.0 40.6 37.0 41.9 50.7 116.3 49.8 47.1 56.8 52.2 52.6

Operating Cycle

287.2 250.7 222.4 252.0 253.7 262.4 301.7 271.7 270.1 235.9 264.1 249.2 246.8

Cash Conversion Cycle

246.2 209.7 182.4 211.4 216.7 220.5 251.0 155.4 220.3 188.8 207.3 197.0 194.2

All numbers in USD currency

Quarterly Financial Ratios Bio-Rad Laboratories

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

23.37 -76.26 13.46 3.65 -39.59 2.33 - -5.48 -31.05 -112.5 -52.59 131.75 30.71 32.77 28.13 44.24 32.59 22.97 18.5 -8.68 20.08 29.03 -27.73 9.02 8.99 22.05 2.78 0.74 0.17 0.42 -0.63 0.58 0.56 0.38 1.69 0.59 0.98 0.61 1.35 0.4 1.1 0.23 1.05 -0.25 1.21 0.71 1.48 1.51 1.71 1.1 2.11 1.63 1.43 1.18

EBITDA per Share

2.5 3.76 1.76 3.34 3.25 2.29 - 3.39 4.34 5.1 - 5.5 4.43 3.62 - 3.93 1.99 3.62 - 2.13 2.08 3 - 4.68 3.77 2.62 - 4.88 2.33 2.03 - 4.51 3.35 1.85 - 4.47 3.59 2.29 - 4.96 4.12 1.98 - 4.69 4.24 2.4 - 5.68 4.82 3.03 - 5.77 4.5 3.41

ROE %

-17.72 -40.20 -7.55 -13.71 -16.89 -13.48 -45.27 -56.78 -29.24 -11.01 31.20 51.21 38.90 40.80 38.53 39.65 21.84 22.47 30.56 0.33 11.53 7.79 9.09 32.52 26.58 20.08 4.17 0.62 0.53 1.00 1.00 3.72 3.76 4.26 4.55 4.34 4.17 4.47 4.07 3.66 2.80 2.94 3.56 4.27 6.71 7.53 8.15 9.46 9.97 9.86 10.21 2.63 2.29 1.89

ROA %

-12.25 -28.12 -5.26 -9.66 -11.90 -25.62 -48.20 -57.06 -12.59 -6.55 23.89 39.22 29.67 31.07 29.34 29.78 16.42 16.44 21.96 0.28 8.31 5.61 6.52 23.22 18.93 14.28 2.86 0.44 0.37 0.68 0.68 2.50 2.52 2.85 3.05 2.88 2.76 2.94 2.66 2.38 1.82 1.90 2.30 2.63 4.07 4.46 4.77 5.46 5.70 5.59 5.75 1.48 1.29 1.07

ROCE %

3.93 4.13 3.27 3.89 3.93 4.24 3.93 4.95 4.85 4.56 3.05 4.16 4.25 3.69 2.39 3.38 3.27 3.73 2.96 3.86 3.77 3.88 3.08 4.64 5.06 3.92 3.73 1.07 0.62 1.72 1.60 4.01 4.44 5.02 4.31 5.83 6.04 6.51 4.55 5.88 5.69 6.01 5.36 8.62 10.56 11.79 9.62 13.86 14.83 15.09 12.00 4.24 3.91 3.85

Current Ratio

3.4 3.3 3.5 3.4 3.4 3.5 3.5 3.4 - 3.4 4.3 4.3 4.3 4.2 4.2 4.2 4.2 4.2 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.2 3.2 3.2 3.2 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 2.9 2.9 2.9 2.9 2.8 2.8 2.8 2.8 2.4 2.4 2.4 2.4 2.3 2.3 2.3 2.3

DSO

63.7 63.6 67.4 68.5 66.3 66.9 - 29.0 30.6 57.9 52.4 49.9 51.5 52.0 48.5 59.1 71.3 64.8 57.4 63.9 62.6 64.7 58.0 65.7 62.2 70.9 68.3 79.4 84.0 76.4 59.5 66.8 65.8 74.0 62.6 76.0 70.6 74.2 57.6 64.9 64.2 71.7 64.0 76.4 73.4 75.0 63.4 73.0 71.3 74.8 64.2 68.0 68.5 -

DIO

249.7 255.5 249.7 238.9 219.0 213.6 - 101.5 93.3 180.7 - 175.1 174.8 171.7 - 202.8 232.8 211.1 - 199.3 190.9 214.3 - 206.2 194.2 215.7 - 230.8 234.7 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

38.6 36.9 34.4 40.2 44.5 43.0 - 21.1 24.8 46.4 - 39.8 39.5 38.9 - 45.5 52.2 44.2 - 19.2 - 23.1 - - - 24.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

313.4 319.2 317.1 307.4 285.3 280.6 - 130.5 124.0 238.5 52.4 224.9 226.2 223.6 48.5 261.9 304.1 275.9 57.4 263.2 253.4 279.0 58.0 271.8 256.4 286.6 68.3 310.2 318.7 76.4 59.5 66.8 65.8 74.0 62.6 76.0 70.6 74.2 57.6 64.9 64.2 71.7 64.0 76.4 73.4 75.0 63.4 73.0 71.3 74.8 64.2 68.0 68.5 -

Cash Conversion Cycle

274.8 282.2 282.8 267.2 240.9 237.6 - 109.4 99.2 192.1 52.4 185.2 186.8 184.8 48.5 216.5 251.9 231.7 57.4 244.0 253.4 255.9 58.0 271.8 256.4 261.9 68.3 310.2 318.7 76.4 59.5 66.8 65.8 74.0 62.6 76.0 70.6 74.2 57.6 64.9 64.2 71.7 64.0 76.4 73.4 75.0 63.4 73.0 71.3 74.8 64.2 68.0 68.5 -

All numbers in USD currency